
Those with epilepsy considering brain surgery to treat their seizures should watch Epilepsy Sparks podcaster Torie Robinson’s recent interview with neurologist Dr. Ricardo Morcos. Like Ms. Robinson, I have drug resistant epilepsy (DRE) and was only able to get my seizures under control after surgical treatment. My surgery was ultimately successful, but also glitchy, which is why I diligently follow stories about new epilepsy treatments. I watched Dr. Morcos’s interview, eager to hear how neurologists are advising DRE patients twelve years after my own experience, which I describe in my memoir, Seizing Control.
An London-based epileptologist, Dr. Morcos used the above graphic to depict the process of determining whether surgery is a good option for a DRE patient. The graphic is modeled after London’s transit or Tube system. As an avid public transit user and a person with epilepsy who got her seizures under control via surgery, I love Dr. Morcos’s analogy. At the heart of the decision map is the Multi-Disciplinary Team, analogous to a city’s transit hub. Dr. Morcos likened it to London’s Piccadilly Circus. In NYC where I grew up, that hub might be Grand Central or Penn Stations. In my current hometown of Boston, the hub is Downtown Crossing or Park Street Stations.
Geography aside, the Multi-Disciplinary Team, or MDT is central to a DRE patient’s surgery decision. In 2014, my team included my neurologist, neurosurgeon, social worker, and a neuropsychologist. Prior to my elective temporal lobectomy, the neuropsychologist assessed my memory, the social worker provided moral support, and the neurologist administered a procedure known as a Wada test.
Named after the doctor who invented it, a Wada test confirms the dominant side of the brain. Though less invasive than surgery, the test is a triple-whammy: a magnetic resonance angiogram, where they examine the brain’s blood vessels, followed by a consecutive barbiturate-dousing of each side of the brain, all the while recording results on an EEG. I was especially alarmed about the daunting technique doctors used to direct the barbiturates to the brain, a Novocain injection in the groin. The Wada test took a few hours and determined that my uncontrollable seizures originated from my right temporal lobe. The test also established that this was far away from my memory and language centers, so my memory and language abilities wouldn’t be impacted. My neurologist concluded I was an excellent surgery candidate.
I am excited to see that the Wada test is not listed among the tests on the Tube lines on Dr. Morcos’s map. There is video-telemetry, where the patient has a week-long EEG that is also captured on video. I underwent that too, and it was not fun. My surgery journey basically followed the above map’s northward black line. But the 2026 MRI technology is so advanced that Wada tests are no longer on there. Today’s MRI results capture brain lesions and details that the older MRI’s couldn’t. This increased brain imaging clarity allows the pre-surgical team to simply view an MRI result to determine whether the seizure-triggering part of the patient’s brain is close to critical brain sections like language and memory centers. If it’s far enough away, then surgery is considered a safe option, as it was in my case. No invasive Wada test required to make this determination. Woohoo!
I love reading about the updated technologies, as they’re indicative of the fact that brain surgery options are expanding. The map’s orange and blue lines have pre-surgery tests that didn’t exist when I had my temporal lobectomy including an intracranial EEG that records the brain for 1-2 weeks using electrodes placed inside of the brain. There’s also a Single Photon Emission Computed Tomography, or SPECT that injects a nuclear tracer during the seizure and monitors the brain’s blood flow. Like the Wada I underwent, I’m sure these tests are also challenging in their own ways. But given all the neurosurgery technological advancements, I’m optimistic that these tests’ results are more detailed and accurate. (Hopefully easier, too.) I suspect a 2026 brain surgery candidate with access to the advanced testing, and detailed results is far less likely to run into the glitches I had.
For those DRE patients whose pre-surgery test results show that brain surgery is not feasible, there are multiple options outlined on Dr. Morcos’s decision map red line. In addition to new anti-seizure medications, innovative neuromodulation options are more accessible and have shown to be effective for some DRE patients. These include vagus nerve stimulation, deep brain stimulation, and responsive nerve stimulation. All three of these involve implanting electric devices that monitor the brain’s electrical activities. When the devices detect potential seizure activity, they send electrical signals to the brain to stop them. While the seizure-control success rates are lower with these devices than brain surgery, I think it’s great that patients who can’t have surgery have additional options.
While the decision map has significantly expanded since my 2014 temporal lobectomy, the Multi-Disciplinary Team is still at the map’s hub. A DRE patient considering surgery should confer with all the MDT’s practitioners, who will clarify the risks of surgery, weigh them against the risks of uncontrollable seizures, and discuss the best route to follow. In the U.S., Epilepsy Centers all have skilled practitioners who can serve as a patient’s pre-surgery MDT. To find an Epilepsy Center, check the National Association of Epilepsy Center’s website.



Leave a Reply